Rezafungin is a novel echinocandin (form of antifungal) with enhanced stability and pharmacokinetics that achieves high plasma drug exposure and allows for once weekly dose administration. References: Hager CL, Larkin EL, Long LA, Ghannoum MA. Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model. J Antimicrob Chemother. 2018 Apr 19. doi: 10.1093/jac/dky153. [Epub ahead of print] PubMed PMID: 29897469.

纯度：≥98%

CAS：1631754-41-0